Mandloi U

Title : Theranostic advances in Alzheimer's disease: structure-guided design of near-infrared fluorescent probes targeting amyloid-beta and cholinergic dysfunction - Mandloi_2026_RSC.Med.Chem__

Author(s) : Mandloi U , Giri N , Kumar S , Modi G

Ref : RSC Med Chem , : , 2026

Abstract :

PubMedSearch : Mandloi_2026_RSC.Med.Chem__

PubMedID: 41531938

Title : Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer's disease - Shankar_2024_Eur.J.Med.Chem_283_117066

Author(s) : Shankar G , Kumar P , Rai S , Ghosh A , Varma T , Wani MA , Kumar S , Mandloi U , Singh GK , Garg P , Kulkarni O , Srikrishna S , Modi G

Ref : Eur Journal of Medicinal Chemistry , 283 :117066 , 2024

Abstract :

PubMedSearch : Shankar_2024_Eur.J.Med.Chem_283_117066

PubMedID: 39667052

Mandloi U

References (2)

1. Theranostic advances in Alzheimer's disease: structure-guided design of near-infrared fluorescent probes targeting amyloid-beta and cholinergic dysfunction - Mandloi_2026_RSC.Med.Chem__

2. Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer's disease - Shankar_2024_Eur.J.Med.Chem_283_117066